Atenolol 2 mg/mL oral solution

Clear solution according to the source.

References: [1]

Beta blocker with cardiovascular indications.
Active-drug context from another product’s labelling; it does not establish stability or dosing of this compounded preparation.

References: [2]

Source describes a clear solution and requires visual inspection.

References: [1]

For the finished product the source specifies:
Light-resistant plastic container, room temperature. Do not refrigerate.

References: [1]

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

Glycerol is miscible with water. This does not establish product microbiological stability.

References: [3]

Glycerol is hygroscopic; limit raw-material exposure to moisture.

References: [3]

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

Glycerol: hazardous reaction with strong oxidising agents.

References: [3]

Glycerin 99.5%: Glycerol is hygroscopic; limit raw-material exposure to moisture.
These are selected facts for identified ingredients; relevant sensitivities and incompatibilities are detailed in the corresponding fields. This is not a complete SDS for every material.

References: [3]

Complete formula-specific PPE is not specified. Select gloves, eye protection and exposure controls using the exact materials’ SDS and the local risk assessment.
Supplementary AEMPS framework: clean long-sleeved laboratory clothing, hair covering and dedicated footwear/overshoes. Powder handling requires suitable eye/respiratory protection; change gloves with activity or damage. Select the exact type/material using SDS and risk assessment.

References: [1] · [4]

A complete formula-specific hazard classification is not established. Assess potency, dust/aerosol, allergens, solvents, microbial risk and cross-contamination using the actual materials and process. Absence of a flag does not establish absence of hazard.

References: [1]

Follow the addition sequence, temperatures and times stated under Preparation Procedure. The specific monograph is not a complete qualification of the local facility/equipment.

References: [1]

Source period: 60 days. Local BUD remains to be assessed.
The source period applies to its exact composition, method and packaging. It is not this batch’s expiry date and cannot be transferred to another vehicle/strength. Calculate the actual date in the blank batch record.

References: [1]

No separate base is identified in the dependency register. Check any commercial vehicles/compound excipients listed in the formula.

References: [1]

Indicative checklist derived from the method: Balance of suitable resolution, Containers and mixing tools compatible with the materials. Selection/qualification is defined locally.

References: [1]

Pulverise tablets and wet with 5 mL glycerin; source permits a slight increase if necessary. Add Ora-Sweet SF progressively, transfer, make to 250 mL and mix.

References: [1]

Use the source dosage form and vehicle. Tablet/capsule strengths follow their labels. Other products or vehicles are not automatically equivalent. The hospital index reports ongoing review against USP <795>.

References: [1]

Light-resistant plastic bottle as specified by the sheet.

References: [1]

Visually examine the final product against the stated appearance. The sheet supplies no validated assay method or numerical microbiological limit.

References: [1]

Light-resistant plastic container, room temperature. Do not refrigerate.

References: [1]

No additional special directions are established beyond the source route, storage and notes. Complete patient details, dose and directions from the prescription.

References: [1]

Atenolol 2 mg/mL oral solution
Strength/variant: __________ Quantity: __________
Batch: __________ Prepared: __________ Use by: __________
Από του στόματος / Oral use
Dose/directions: __________
Storage: Light-resistant plastic container, room temperature. Do not refrigerate.

References: [1]